KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovoCure (NVCR) EBT Margin (2016 - 2026)

NovoCure's EBT Margin history spans 13 years, with the latest figure at 39.79% for Q1 2026.

  • On a quarterly basis, EBT Margin fell 2024.0% to 39.79% in Q1 2026 year-over-year; TTM through Mar 2026 was 25.98%, a 510.0% decrease, with the full-year FY2025 number at 20.79%, up 88.0% from a year prior.
  • EBT Margin hit 39.79% in Q1 2026 for NovoCure, down from 23.49% in the prior quarter.
  • Over the last five years, EBT Margin for NVCR hit a ceiling of 1.83% in Q1 2022 and a floor of 42.76% in Q2 2023.
  • Historically, EBT Margin has averaged 24.81% across 5 years, with a median of 22.85% in 2024.
  • Biggest five-year swings in EBT Margin: crashed -3998bps in 2023 and later soared 2765bps in 2024.
  • Tracing NVCR's EBT Margin over 5 years: stood at 25.35% in 2022, then dropped by -14bps to 28.8% in 2023, then fell by -19bps to 34.23% in 2024, then surged by 31bps to 23.49% in 2025, then crashed by -69bps to 39.79% in 2026.
  • Business Quant data shows EBT Margin for NVCR at 39.79% in Q1 2026, 23.49% in Q4 2025, and 17.96% in Q3 2025.